Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke

Cardiovasc J Afr. 2010 Nov-Dec;21(6):342-3.
No abstract available

Publication types

  • News

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Evidence-Based Medicine
  • Humans
  • Morpholines / adverse effects
  • Morpholines / therapeutic use*
  • Rivaroxaban
  • Stroke / etiology
  • Stroke / prevention & control*
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*
  • Treatment Outcome
  • Warfarin / adverse effects
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Morpholines
  • Thiophenes
  • Warfarin
  • Rivaroxaban